Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis

Area of Science:

• Nephrology
• Infectious Diseases
• Public Health

Background:

• Bloodstream infections (BSIs) are a major cause of morbidity and mortality in hemodialysis patients.
• Central vein catheters are the primary source of vascular access-associated BSIs in this population.
• Current prevention strategies, including Centers for Disease Control and Prevention (CDC) core interventions, have not fully eradicated BSIs in hemodialysis settings.

Purpose of the Study:

• To review recent advances in prophylactic therapies for hemodialysis-associated bloodstream infections.
• To discuss the limitations and potential adverse effects of novel BSI prevention options.
• To address the ongoing challenge of unacceptable BSI rates in US hemodialysis patients.

Main Methods:

• Literature review of recent advances in prophylactic therapies for hemodialysis BSIs.
• Analysis of the effectiveness and safety profiles of emerging BSI prevention strategies.
• Discussion of factors contributing to persistent high BSI rates, including adherence to aseptic technique.

Main Results:

• Central vein catheters are associated with the majority of vascular access-related BSIs in hemodialysis.
• Existing CDC interventions are effective but may not address all contributing factors to BSIs.
• There is a critical need for novel prophylactic therapies to further reduce BSI incidence.

Conclusions:

• Despite established interventions, hemodialysis BSIs persist at unacceptable rates.
• Lapses in aseptic technique and unaddressed factors necessitate new preventive approaches.
• Further research into novel prophylactic therapies is crucial for improving patient safety in hemodialysis.